NovaBridge Biosciences (NBP) Debt Ratio (2018 - 2023)

NovaBridge Biosciences (NBP) reported Debt Ratio of 0.01 for Q4 2023, up 146.49% year-over-year from 0.0 in Q4 2022, and up 29.81% quarter-over-quarter from 0.01 in Q2 2023.

NovaBridge Biosciences (NBP) Debt Ratio (2018 - 2023) Analysis & Trends

NovaBridge Biosciences (NBP) has 4 years of Debt Ratio data on file, last reported at 0.01 in Q4 2023.

  • Debt Ratio for Q4 2023 came in at 0.01, up 146.49% year-over-year; the trailing twelve-month figure through Dec 2023 was 0.01 (up 146.49% YoY), and the FY2023 annual result was 0.01, up 135.07% from the prior year.
  • Debt Ratio climbed to 0.01 in Q4 2023 per NBP's latest filing, from 0.01 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.03 in Q4 2019 and troughed at 0.0 in Q4 2022.
  • A 3-year average of 0.01 and a median of 0.01 in 2023 frame the typical range for Debt Ratio.
  • The sharpest annual moves came in 2019 and 2023: Debt Ratio dropped 14.54% in 2019, then jumped 146.49% in 2023.
  • A 3-year view of Debt Ratio shows it stood at 0.03 in 2019, then slumped by 83.83% to 0.0 in 2022, then jumped by 146.49% to 0.01 in 2023.
  • Business Quant data shows NBP's Debt Ratio at 0.01 in Q4 2023, 0.01 in Q2 2023, and 0.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 0.18
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -
9 Abivax 90.15 Bn 90.15 Bn - -
10 NovaBridge Biosciences 328.19 Mn 117.34 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 0.01
Jun 30, 2023 0.01
Dec 31, 2022 0.00
Dec 31, 2019 0.03
Dec 31, 2018 0.03